Table 2.
Variables | Serum miR-21 expression, mean ± SD (n = 186) | P | Tissue miR-21 expression, mean ± SD (n = 166) | P |
---|---|---|---|---|
Age, y† | ||||
≤67 | 0.0062±0.0047 (n = 88) | .22 | 3.16±1.46 (n = 80) | .07 |
>67 | 0.0059±0.0052 (n = 98) | 3.64±1.73 (n = 86) | ||
Sex | ||||
Male | 0.0059±0.0053 (n = 106) | .30 | 3.23±1.46 (n = 100) | .36 |
Female | 0.0062±0.0044 (n = 80) | 3.52±1.72 (n = 66) | ||
Tumor location | ||||
Right side | 0.0073±0.0065 (n = 59) | .16 | 3.38±1.45 (n = 56) | .70 |
Left side | 0.0058±0.0048 (n = 127) | 3.33±1.57 (n = 110) | ||
Tumor type | ||||
Colon cancer | 0.0063±0.0055 (n = 110) | .89 | 3.50±1.51 (n = 101) | .07 |
Rectal cancer | 0.0062±0.0054 (n = 76) | 3.11±1.52 (n = 65) | ||
Tumor size, cm‡ | ||||
≤5 | 0.0048±0.0035 (n = 91) | .004 | 3.13±1.47 (n = 78) | .01 |
>5 | 0.0070±0.0056 (n = 95) | 3.67±1.71 (n = 88) | ||
Serosal invasion | ||||
Negative | 0.0051±0.0041 (n = 58) | .08 | 2.82±1.37 (n = 47) | .004 |
Positive | 0.0064±0.0052 (n = 128) | 3.64±1.66 (n = 119) | ||
Lymphatic invasion | ||||
Negative | 0.0058±0.0041 (n = 46) | .83 | 3.04±1.52 (n = 39) | .02 |
Positive | 0.0061±0.0051 (n = 140) | 3.53±1.64 (n = 127) | ||
Venous invasion | ||||
Negative | 0.0058±0.0045 (n = 108) | .53 | 3.36±1.53 (n = 91) | .60 |
Positive | 0.0064±0.0054 (n = 78) | 3.47±1.73 (n = 75) | ||
Lymph node metastasis | ||||
Negative | 0.0055±0.0042 (n = 106) | .12 | 3.24±1.48 (n = 92) | .11 |
Positive | 0.0068±0.0057 (n = 80) | 3.62±1.76 (n = 74) | ||
Distant metastasis | ||||
Negative | 0.0055±0.0045 (n = 145) | .01 | 3.21±1.37 (n = 131) | .02 |
Positive | 0.0078±0.0060 (n = 41) | 4.18±2.19 (n = 35) |
* SD = standard deviation.
† The median age was 67 years.
‡ The median tumor size was 5 cm.